Viewing Study NCT03471260

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:04 AM
Ignite Modification Date: 2026-02-10 @ 10:40 PM
Study NCT ID: NCT03471260
Status: RECRUITING
Last Update Posted: 2025-10-03
First Post: 2018-03-02
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies
Sponsor: M.D. Anderson Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Myeloid Leukemia View
None Hematopoietic and Lymphoid System Neoplasm View
None Myelodysplastic Syndrome View
None Myeloproliferative Neoplasm View
None Recurrent Acute Myeloid Leukemia View
None Refractory Acute Myeloid Leukemia View
Keywords: